Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,901 | 96 | 92.4% |
| Education | $155.70 | 3 | 7.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,007 | 50 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $264.01 | 12 | $0 (2024) |
| Janssen Biotech, Inc. | $229.19 | 10 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $134.29 | 7 | $0 (2024) |
| Amgen Inc. | $116.73 | 5 | $0 (2024) |
| UCB, Inc. | $114.44 | 5 | $0 (2024) |
| Lilly USA, LLC | $71.99 | 3 | $0 (2024) |
| PFIZER INC. | $49.76 | 3 | $0 (2024) |
| LEO Pharma Inc. | $38.07 | 2 | $0 (2024) |
| Galderma Laboratories, L.P. | $18.07 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,512 | 70 | ABBVIE INC. ($699.27) |
| 2023 | $341.21 | 20 | ABBVIE INC. ($243.57) |
| 2022 | $203.69 | 9 | ABBVIE INC. ($64.56) |
All Payment Transactions
99 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $32.44 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: Immunology | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $9.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.36 | General |
| Category: Immunology | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $47.99 | General |
| Category: Immunology | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.24 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Immunology | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.58 | General |
| Category: Immunology | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.48 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: DERMATOLOGY | ||||||
| 09/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $18.07 | General |
| 09/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Immunology | ||||||
| 09/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 3,755 | 7,272 | $1.6M | $189,786 |
| 2022 | 16 | 2,404 | 3,825 | $670,309 | $119,768 |
| 2021 | 14 | 1,534 | 2,229 | $348,522 | $87,940 |
| 2020 | 15 | 489 | 967 | $139,270 | $51,406 |
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 875 | 1,136 | $298,768 | $50,476 | 16.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 731 | 938 | $284,805 | $25,741 | 9.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 405 | 478 | $180,684 | $24,530 | 13.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 241 | 273 | $114,387 | $15,827 | 13.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 577 | 3,327 | $279,468 | $12,238 | 4.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 226 | 226 | $72,546 | $11,701 | 16.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 72 | 99 | $72,697 | $9,274 | 12.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 62 | 79 | $54,975 | $7,039 | 12.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 34 | 36 | $36,072 | $6,809 | 18.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 115 | 187 | $38,335 | $5,419 | 14.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 143 | 158 | $23,310 | $4,092 | 17.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 49 | $18,228 | $3,434 | 18.8% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 33 | 46 | $26,234 | $3,297 | 12.6% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 35 | 37 | $34,637 | $3,032 | 8.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 62 | 62 | $13,855 | $2,204 | 15.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $9,006 | $1,508 | 16.7% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 11 | 13 | $9,872 | $1,207 | 12.2% |
| 69100 | Biopsy of ear | Office | 2023 | 17 | 19 | $12,874 | $770.43 | 6.0% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 13 | $8,030 | $744.36 | 9.3% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 17 | 19 | $3,834 | $400.57 | 10.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 25 | 58 | $947.14 | $43.73 | 4.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 591 | 638 | $116,855 | $31,646 | 27.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 271 | 290 | $80,498 | $15,779 | 19.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 198 | 212 | $70,796 | $14,590 | 20.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 405 | 435 | $116,397 | $13,458 | 11.6% |
About Erin Devanney, FNP-C
Erin Devanney, FNP-C is a Family healthcare provider based in Nags Head, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2019. The National Provider Identifier (NPI) number assigned to this provider is 1154882165.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Erin Devanney, FNP-C has received a total of $2,057 in payments from pharmaceutical and medical device companies, with $1,512 received in 2024. These payments were reported across 99 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,901).
As a Medicare-enrolled provider, Devanney has provided services to 8,182 Medicare beneficiaries, totaling 14,293 services with total Medicare billing of $448,899. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Nags Head, NC
- Active Since 03/31/2019
- Last Updated 10/14/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1154882165
Products in Payments
- SKYRIZI (Biological) $524.14
- RINVOQ (Biological) $415.97
- DUPIXENT (Biological) $264.01
- TREMFYA (Drug) $229.19
- Sotyktu (Drug) $134.29
- Otezla (Drug) $116.73
- Bimzelx (Biological) $68.31
- HUMIRA (Biological) $58.84
- EUCRISA (Drug) $49.76
- OLUMIANT (Drug) $46.37
- Cimzia (Drug) $46.13
- ADBRY (Biological) $38.07
- TALTZ (Drug) $25.62
- COSENTYX (Biological) $13.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Nags Head
Dr. Marina Turner, Fnp-Bc, FNP-BC
Family — Payments: $1,490
Lori Lancsek
Family — Payments: $1,235
Ms. Patricia Johnson, F.n.p., C.n.m, F.N.P., C.N.M
Family — Payments: $282.18
Amanda Williams, Np-C, NP-C
Family — Payments: $245.54
Katherine Caton, Np, NP
Family — Payments: $122.56
Christine Coleman, Np, NP
Family — Payments: $79.15